Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001143313-17-000016
Filing Date
2017-04-21
Accepted
2017-04-21 13:57:54
Documents
2
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1213
2 ruleprovisionnotice.htm EX-99.25 3352
  Complete submission text file 0001143313-17-000016.txt   6679
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-36457 | Film No.: 17775205
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 Wall Street New York NY 10005
Business Address 11 Wall Street New York NY 10005 212-656-5024
NYSE MKT LLC (Filed by) CIK: 0001143313 (see all company filings)

EIN.: 522127241
Type: 25-NSE